Trichotillomania and Skin-Picking Disorder: Different Kinds of OCD

Trichotillomania, also known as hair-pulling disorder, is characterized by the repetitive pulling out of one’s own hair leading to hair loss and functional impairment (1) (see box for diagnostic criteria). The most common sites pulled include the scalp, eyebrows, and eyelashes, although any bodily site with hair can be affected (2, 3). Pulling from multiple sites is common, and pulling episodes can last from a few minutes to several hours (4). Nationwide epidemiological studies of trichotillomania are lacking, but small studies examining the prevalence of trichotillomania among college students in the United States, adolescents in Israel, and older adults within the community have found current rates ranging from 0.5% to 2.0% (5–7).

The onset of hair pulling occurs generally in late childhood or early adolescence, although the onset of pulling behaviors can occur at any age (4, 8). Trichotillomania appears to have a similar clinical presentation across cultures (6, 9). In adults, trichotillomania has a large female preponderance; however, in childhood, sex distribution has been found to be equal (10, 11). Trichotillomania is frequently associated with reduced self-esteem and avoidance of social situations because of shame and embarrassment from the pulling and its consequences (3, 12). Although trichotillomania interferes with a person’s quality of life, the majority (approximately 65%) of individuals never seek treatment (3).

The clinical presentation of trichotillomania varies. Individuals may report one or many triggers for their pulling, and these include sensory triggers, such as feeling of the hair or the scalp; emotional triggers, such as feeling anxious, bored, or angry; and cognitive triggers, such as thinking about hair and appearance or rigid thinking (4). Many patients report not being fully aware of their pulling behaviors, also referred to as “automatic” pulling, whereas “focused” pulling generally occurs when the patient sees or feels a hair that is “not right” or feels that the hair is coarse, kinky, or “out of place” (4). Most patients pull with varying degrees of focused and automatic pulling, which can fluctuate across time.

Skin-picking disorder, which is also referred to as pathological skin picking, neurotic excoriation, dermatillomania, or psychogenic excoriation, is characterized by repetitive and compulsive picking of skin leading to tissue damage (1) (see box for diagnostic criteria). Although most individuals at some time pick at their skin, either to smooth out irregularities or to improve blemishes or acne, clinicians must differentiate between normal picking and more pathological forms. The diagnostic criteria for skin-picking disorder require that picking be recurrent and result in skin lesions, thereby reflecting the frequency and intensity of the picking (1). In addition, the clinical diagnosis requires that the picking result in the person feeling distressed or impaired.

Community prevalence studies in the United States have found that skin-picking disorder is relatively common. In a study of 354 adult participants, 19 (5.4%) reported significant picking with associated distress/impact (13). A second study of 2,513 telephone interviews in a representative sample found that 1.4% of individuals picked to the point of having noticeable skin damage and reported distress or impairment because of the picking (14). Research suggests that the age of onset for skin-picking disorder varies substantially and may occur during childhood, adolescence, or adulthood (15, 16). The clinical characteristics of skin-picking disorder appear to be the same across age cohorts and cultures (16). Many individuals with excoriation disorder report that the behavior began with the onset of a dermatological condition such as acne but continued even after the condition cleared.

The phenomenology of skin-picking disorder bears striking similarities to that of trichotillomania. Individuals with skin-picking disorder spend a significant amount of time each day picking their skin, with many reporting that the picking behavior occupies several hours each day (17). Although the face is the most commonly reported site of picking, the hands, fingers, arms, and legs are also common targets. Picking from more than one body area is normal, with one study finding that people picked at an average of 4.5 sites (17). The time spent picking and the consequences of picking (such as scarring) result in dysfunction related to work and social activities (18). Triggers to pick vary greatly among individuals, and multiple triggers are the norm. Stress, anxiety, time away from scheduled activities, boredom, and feeling tired or angry have all been reported as triggers (16).

Treatment strategies are based on an accurate diagnosis. Unfortunately, misdiagnosis of trichotillomania and skin-picking disorder is common (Table 1). Individuals may be misdiagnosed with obsessive-compulsive disorder (OCD), an anxiety disorder, body dysmorphic disorder, or even drug addiction. Because treatments differ between these disorders and trichotillomania and skin-picking disorder, proper diagnosis is necessary.

The evidence base for psychotherapy for trichotillomania and skin-picking disorder is small but suggests the use of behavioral therapy for both disorders. Behavioral therapy for trichotillomania has generally used habit reversal therapy (HRT) and may have included components of acceptance and commitment therapy and dialectical behavioral therapy as well. There have been seven controlled studies of behavioral therapy, using HRT alone or with other components, for trichotillomania and two controlled psychosocial treatment studies for skin-picking disorder. The studies for skin-picking disorder involved the uses of HRT and cognitive-behavioral therapy. There are no controlled studies of other traditional therapies.

HRT was first developed approximately 40 years ago by Azrin and Nunn for the treatment of nervous habits and tics (35). Although used in multiple forms throughout the years, the core aspects of HRT include self-monitoring (i.e., asking the patient to track his or her hair pulling, picking, etc.), awareness training, competing response training, and stimulus control procedures (i.e., modifying the environment to reduce cues for hair pulling or skin picking). Self-monitoring may begin by using a self-monitoring form that the patient fills out on a daily basis and maintains throughout the therapy period. Awareness training consists of having the therapist ask the patient to describe in detail and even reenact the picking or pulling. The patient also needs to identify triggers for the pulling and picking. In competing response training, patients are taught at the earliest sign of pulling or the urge to pull to engage in a behavior that is physically incompatible with pulling for a brief period until the urge subsides. For example, a woman who pulls her hair might clench her fists or place her hands underneath her legs upon identifying a warning sign for hair pulling. Competing responses must be opposite to those of the targeted behavior, they must be maintained for 1 minute or until the urge to pull or pick subsides, and they should be socially inconspicuous. Stimulus control consists of modifying the environment to reduce the triggers of pulling or picking. For example, if a man pulls his hair at work only when his office door is closed, then he needs to keep the door open during the work day. HRT is similar to many other types of behavioral therapy. HRT differs somewhat from standard cognitive-behavioral therapy in that the focus of HRT is on behavioral change and not generally on cognitive strategies to address dysfunctional thoughts that precipitate hair pulling.

HRT appears to be superior to wait list and minimal attention control groups based on controlled studies (36). In addition, HRT has shown benefit with the addition of components of acceptance and commitment therapy and dialectical behavior therapy (37, 38). HRT can be delivered in person, online with use of a self-help method, or in a group format (36, 39, 40). Acute treatment gains obtained from HRT have been generally maintained from 3 to 6 months.

Typically, HRT is conducted on a weekly basis, although higher severity of the disorder may necessitate more frequent sessions. HRT has shown benefit in many different frequency formats, and anywhere from 4 to 22 sessions (usually 60 minutes each) may be helpful. Although in practice many clinicians use a combination of HRT and more traditional cognitive therapy, the empirical data support HRT as a first-line psychotherapy treatment of these disorders.

Currently, no pharmacotherapies are universally accepted as first-line treatments of trichotillomania or skin-picking disorder. Eight double-blind studies have been published for the treatment of trichotillomania and four double-blind, placebo-controlled clinical trials have been published for skin-picking disorder. Generally, pharmacotherapy should be avoided in children. A recent Cochrane review concluded that although clomipramine has demonstrated some benefit for trichotillomania, there is no strong evidence of a treatment effect for selective serotonin reuptake inhibitors (SSRIs) (41).

Glutamatergic agents have shown some promise in trichotillomania and may have a useful role in the treatment of skin-picking disorder as well. One key example is N-acetylcysteine (NAC), which has demonstrated benefit in a double-blind, placebo-controlled study for trichotillomania and in case reports for skin-picking disorder (42, 43). On the basis of trichotillomania data, NAC may be useful for reducing the urge to pick. Previous research has used up to 1,200 mg twice a day as a target dose, with expected clinical benefits being observed after approximately 9 weeks. Side effects are generally mild and usually only involve some bloating and flatulence.

On the basis of data from their potential efficacy in OCD, antipsychotic medications have also been used for the treatment of trichotillomania. One small (N=23) double-blind, placebo-controlled study of olanzapine found the medication significantly beneficial in reducing the symptoms of trichotillomania after 12 weeks at a mean dose of 10.8 mg/day (44). Olanzapine has been associated with metabolic syndrome; therefore, the decision to use it in the treatment of trichotillomania and skin-picking disorder needs to be tempered by its adverse side effect profile.

Opioid antagonists (e.g., naltrexone), which reduce self-licking in dogs with acral lick dermatitis, may also represent a viable option for trichotillomania and skin-picking disorder, although such benefit has been limited to small samples (case reports of single patients, often with Prader-Willi syndrome) of individuals with excoriation disorder. However, according to an 8-week double-blind, placebo-controlled study of naltrexone (dosing of 50 mg/day up to 150 mg/day) in the treatment of 52 patients with trichotillomania, naltrexone may be useful for individuals with hair-pulling or skin-picking disorder who have a family history positive for alcohol use disorders (45).

Psychotherapeutic and pharmacological treatments have documented evidence as effective monotherapies as well as in a combined treatment strategy (46). Although the optimal sequence of treatments has not yet been identified, we recommend HRT monotherapy for individuals who are motivated to cooperate with therapy demands, do not have severe depressive symptoms, or prefer not to take medications. Medication treatment as monotherapy (e.g., NAC, olanzapine, clomipramine) is recommended for individuals who are not able to engage in HRT, report a previous response to a medication, or prefer medication treatments to psychotherapy.

Co-occurring anxiety and depression are common among individuals with trichotillomania and skin-picking disorder. If possible, assessment should be designed to identify the temporal relationship of these comorbidities with trichotillomania and skin-picking disorder—for example, is the depression or anxiety secondary to the effects of the hair pulling or skin picking? If so, then focusing on the hair pulling or skin picking would be the recommended initial approach. If such a temporal relationship is unclear, however, then expanding the behavioral therapy to also include cognitive approaches could be beneficial for both disorders. In terms of pharmacotherapy, many individuals may need an antidepressant for comorbid diagnoses, even when the data suggest that antidepressants are largely ineffective for trichotillomania and skin-picking disorder.

If trichotillomania and skin-picking disorder are left untreated, the course is usually chronic, often with waxing and waning symptoms. Without treatment, response rates in adults are low (approximately 14%) (3). When diagnosed early and treated appropriately, however, up to 50% of individuals may experience symptom reduction, at least in the short term (47). Therefore, accurate and early diagnosis followed by evidence-based treatment is needed to prevent associated disability.